Efficacy of FFP3 respirators for prevention of SARS-CoV-2 infection in healthcare workers

Authors
Matheson, nicholas 
Illingworth, christopher 

Loading...
Thumbnail Image
Type
Article
Change log
Abstract

Background: Respiratory protective equipment recommended in the UK for healthcare workers (HCWs) caring for patients with COVID-19 comprises a fluid resistant surgical mask (FRSM), except in the context of aerosol generating procedures (AGPs). We previously demonstrated frequent pauci- and asymptomatic SARS-CoV-2 infection HCWs during the first wave of the COVID-19 pandemic in the UK, using a comprehensive PCR-based HCW screening programme (Rivett et al., 2020; Jones et al., 2020). Methods: Here, we use observational data and mathematical modelling to analyse infection rates amongst HCWs working on “red” (COVID-19) and “green” (non-COVID-19) wards during the second wave of the pandemic, before and after the substitution of filtering face piece 3 (FFP3) respirators for FRSMs. Results: Whilst using FRSMs, HCWs working on red wards faced an approximately 31-fold (and at least 5-fold) increased risk of direct, ward-based infection. Conversely, after changing to FFP3 respirators, this risk was significantly reduced (52-100% protection). Conclusions: FFP3 respirators may therefore provide more effective protection than FRSMs for healthcare workers caring for patients with COVID-19, whether or not AGPs are undertaken. Funding: Wellcome Trust, Medical Research Council, Addenbrooke’s Charitable Trust, NIHR Cambridge Biomedical Research Centre, NHS Blood and Transfusion, UKRI.

Publication Date
2021-11-16
Online Publication Date
2021-11-16
Acceptance Date
2021-11-07
Keywords
COVID-19, FFP3, PPE, SARS-CoV-2, epidemiology, global health, healthcare worker, infectious disease, mask, microbiology, viruses, Adult, Aerosols, Aged, COVID-19, Health Personnel, Humans, Incidence, Infection Control, Masks, Middle Aged, Models, Theoretical, Respiratory Protective Devices, SARS-CoV-2, United Kingdom, Young Adult
Journal Title
eLife
Journal ISSN
2050-084X
2050-084X
Volume Title
10
Publisher
eLife Sciences Publications Ltd
Sponsorship
Wellcome Trust (108070/Z/15/Z)
Addenbrooke's Charitable Trust (ACT) (900275 Minute 47/20B)
Medical Research Council (MR/P008801/1)
MRC (via University of Warwick) (MR/V038613/1)